Glanbia Plc · EURONEXT:GL9
Glanbia — Glanbia Plc Ord — H1 2026 Earnings Presentation
19 slides from Glanbia's earnings presentation, Aug 6, 2026
Slide 1: Half Year 2026 Results
H A L F Y E A R 2 0 2 6 R E S U LT S 06 AUGUST 2026 Hugh McGuire Mark Garvey Chief Executive Officer Chief Financial Officer
Slide 2: Important Notice
I M P O R T A N T N O T I C E This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertainties, including both econ
Slide 3: Agenda
Agenda 1 B U S I N E S S R E V I E W F I N A N C E 2 R E V I E W 3 Q & A 3 | Glanbia PLC HY Results 2026
Slide 4: Highlights
HIGHLIGHTS HY 2026 H1 2026 Group performance ahead of expectations with adjusted EPS 1 of 81.24 $cent (+30.0%) with strong momentum across all three segments PN LFL revenue2 +16.9% driven by strong volume and pricing growth with Optimum Nutrition growing LFL revenue +25.2% H&N LFL revenue2 +12.0% dr
Slide 5: Business Review
1 BUSINESS REVIEW Hugh McGuire Chief Executive Officer 5 | Glanbia PLC HY Results 2026
Slide 6: Performance Nutrition (PN)
PERFORMANCE NUTRITION (PN) Strong performance in H1 driven by Optimum Nutrition $m HY26 Growth%1 Revenue 917.2 6.7% EBITDA 115.2 7.4% EBITDA margin 12.6% +10bps • LFL revenue2 +16.9% • Volume +9.3% driven by accelerating category growth, new distribution and innovation Americas International • Prici
Slide 7: World's #1 Sports Nutrition Brand With More Growth Potential
WORLD’S #1 SPORTS NUTRITION BRAND WITH MORE GROWTH POTENTIAL Activation of The Optimum Optimum Nutrition L13W US Advantage Campaign Celebrating 40 Years’ H1 LFL revenue growth1 consumption2 +25.2% +23.5% Volume growth of +16.4% driven by category growth across key channels and markets, increased dis
Slide 8: Health & Nutrition (H&N)
H E A LT H & N U T R I T I O N ( H & N ) Strong topline growth and margin expansion through premix and flavours $m HY26 Growth%1 Revenue 368.5 +15.6% EBITDA 67.9 +9.5% EBITDA margin 18.4% (110bps) • LFL revenue2 +12.0%: • Volume +14.3% driven by continued strong growth across core end-use markets of
Slide 9: Dairy Nutrition (DN)
D A I RY N U T R I T I O N ( D N ) Strong performance driven by protein solutions $m HY26 Growth%1 Revenue 793.7 +3.8% EBITDA 92.3 +28.2% EBITDA margin 11.6% +220bps • LFL revenue2 +3.8%: • Volume +4.6% driven by strong growth in protein solutions • Pricing -0.8% driven by strong whey protein market
Slide 10: Finance Review
2 FINANCE REVIEW Mark Garvey Chief Financial Officer 10 | Glanbia PLC HY Results 2026
Slide 11: HY Financial Summary
H Y 2 0 2 6 F I N A N C I A L S U M M A RY $2.1bn REVENUE +7.0% constant currency increase $275.4m EBITDA +14.1% constant currency increase EBITDA +80bps constant currency vs. HY 2025 13.2% M ARGIN PN +10bps, H&N -110bps and DN +220bps constant currency ADJUSTED 81.24$c EPS +30% constant currency in
Slide 12: Strong Balance Sheet
STRONG BALANCE SHEET DEBT CAPITAL SHAREHOLDER EXPENDITURE RETURNS Net Debt $731 million HY26 capex of $50m Interim dividend increased by 10% Total committed facilities of FY26 capex expected to $1.35bn be $100m – $110m €100m returned via share buybacks2 Net debt to adjusted EBITDA of 1.4 times1 1 Ne
Slide 13: Other Financial Matters
O T H E R F I N A N C I A L M AT T E R S TRANSFORMATION Upgraded annual savings target from $60m to $70m by PROGRAMME FY27 EXCEPTIONAL Charges of $21.6m largely related to Group-wide transformation ITEMS programme and contingent consideration for Sweetmix acquisition JOINT Increase of $9.3m to $12.7
Slide 14: FY26 Outlook Ahead Of Medium-Term Growth Algorithm
FY26 OUTLOOK AHEAD OF MEDIUM -TERM GROWTH ALGORITHM PN H&N DN Revenue growth: 12% – 14% Revenue growth: 8% – 10% EBITDA in the range of EBITDA margin progression EBITDA margin: 17% – 19% $170m – 180m Adj. EPS1 growth of 17% – 20% OCF Conversion 85%+ 14 | Glanbia PLC HY Results 2026 1 On a constant c
Slide 15: Delivering Better Nutrition
DELIVERING BETTER NUTRITION 1 High-growth categories with leading brands and ingredients driven by consumer megatrends 2 Sharpened and focused operating model and portfolio to capture the growth 3 Our people, portfolio, and firepower will continue to drive strong shareholder returns 15 | Glanbia PLC
Slide 16: A Performance Driven Purpose Led Global Nutrition Company
A PERFORMANCE DRIVEN PURPOSE L E D G L O B A L N U T R I T I O N C O M PA N Y 16 | Glanbia PLC HY Results 2026
Slide 17: Appendices
A APPENDICES 17 | Glanbia PLC HY Results 2026
Slide 18: PN HY 2026 Revenue Overview
P N H Y 2 0 2 6 R E V E N U E O V E RV I E W 4% 11% 4% 34% 6% 42% 23% BY BY BY REGION CHANNEL F O R M AT 58% 86% 32% L F L G R O W T H 1: Americas +9.2% Online +15.0% Powders +21.8% International +29.6% FDMC +14.2% RTE -23.4% Distributor +29.5% RTD -2.3% Specialty +7.7% Other +31.1% 18 | Glanbia PLC
Slide 19: Quarterly Revenue Trends
Q U A R T E R LY R E V E N U E T R E N D S HY 2026 results summary (pre-exceptional)) Revenue Progression HY 2026 versus HY 2025 Constant Currency Movement Acquisitions / Total Constant Volume Price Life-for-like (LFL) (disposals) Currency Performance Nutrition 9.3% 7.6% 16.9% (10.2%) 6.7% Health &